StockData
Cadrenal Therapeutics, Inc. logo

Cadrenal Therapeutics, Inc. (CVKD) stock

CVKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/30
$1.72−0.16 (-8.51%)

Close on Nov 18, 2026Market cap $6.14MP/E –Yield 959.30%

Cadrenal Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Cadrenal Therapeutics

Cadrenal Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Cadrenal Therapeutics figures

See a number that looks wrong?